0 By onl101 In Press ReleasePosted March 28, 2017ONL Therapeutics Strengthens Leadership with Addition to Board of Directors and Expansion of Operations Team READ MORE
0 By onl101 In NewsPosted March 27, 2017After $1M NEI Grant, ONL Therapeutics Closer to Clinical TrialsXconomy ONL Therapeutics, the Ann Arbor, MI-based biotech startup working on sight-preserving therapies for patients with retinal diseases, is one step closer to clinical trials, thanks to a cash [...] READ MORE
0 By onl101 In NewsPosted March 21, 2017ONL Therapeutics Gets Federal Grant of $1 MillionCrain’s Company also raises $1 million to fund drug for patients with retinal detachments… Read the Article READ MORE
0 By onl101 In Press ReleasePosted March 21, 2017ONL Therapeutics Receives Nearly $1.0 Million Grant from National Eye Institute for Continued Advancement of ONL1204 Program READ MORE